Heirs not liable for treatment debts.

If a patient dies while being treated with an investigational drug, biological product, or device, or an individualized investigational treatment, the patient’s heirs are not liable for any outstanding debt related to the treatment or lack of insurance due to the treatment. 2017 Acts, ch 130, §5 ; 2025 Acts, ch 80, §4 Section amended